The present results showing that CEP-1347 in combination with RG7112 effectively activated the p53 pathway and inhibited the growth of malignant brain tumor cells corroborate the theoretical superiority of this combination, which warrants further study in clinical settings. The gene discussed is TP53; the disease is brain neoplasm.